No Data
No Data
Express News | Guardant Health and Bayshore Healthcare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
Guardant Health and Bayshore HealthCare Partner to Expand Access to Advanced Precision Oncology Testing in Canada
Unusual Options Activity: STX, MSFT and Others Attract Market Bets, STX V/OI Ratio Reaches 166.7
EST Mar 28th Closing Delivery - In the last three hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options
Guardant Health's Strategic Growth: Shield's Coverage Expansion and Revenue Potential
Craig-Hallum Maintains Guardant Health(GH.US) With Buy Rating
Guardant Health Price Target Maintained With a $55.00/Share by Stephens & Co.